SB92 Alabama 2012 Session

Summary

Primary Sponsor

Cam Ward

Republican

Session

Regular Session 2012

Title

Health, Hemophilia and bleeding disorders, pharmacy, insurance requirements, von Willebrand's screening, Public Health to administer, Hemophilia Standards of Care Act

Summary

SB92 would set standards of care for people with hemophilia and other bleeding disorders, regulate home-use blood clotting products and related services, require insurer coverage, and mandate screening before certain uterine procedures.

What This Bill Does

The bill creates standards of care for hemophilia and other bleeding disorders and defines related terms. Pharmacists and pharmacies that distribute home-use blood clotting products must meet specific requirements, and the Department of Public Health could issue implementing rules and maintain a list of compliant home-care pharmacies. Health insurers would have to cover clotting factor products, physician services, inpatient and outpatient care, and required diagnostic lab services for these conditions. Physicians must screen for von Willebrand’s disease and other bleeding disorders before advising an invasive uterine procedure for menorrhagia.

Who It Affects

• People with hemophilia and other bleeding disorders would gain defined standards of care, insurer coverage for necessary treatments and services, and required medical screening before certain procedures.
• Healthcare providers and organizations (pharmacies, 340B programs, physicians, and the Department of Public Health) would need to comply with new standards, report requirements, and implement rules and lists of compliant pharmacies.

Key Provisions

• Establishes the Hemophilia Standards of Care Act and defines key terms such as 340B program, bleeding disorder, blood clotting product, and von Willebrand disease.
• Pharmacies that dispense home-use blood clotting products must meet detailed requirements (prescription adherence, substitutions with prior approval, supply of multiple brands and assay ranges, provision of infusion equipment, 24/7 pharmacist on-call, 24-hour shipping, record-keeping, payment assistance, cost information, recall notices, waste disposal, and an emergency plan filed with the department). The Department of Public Health may issue implementing rules and maintain a list of compliant home-care pharmacies.
• Insurers must provide coverage for services for persons with hemophilia and related bleeding disorders, including inpatient and outpatient physician services, blood clotting factor products, physician fees, and required diagnostic laboratory services.
• Physicians must request a medical screening for von Willebrand’s disease and other bleeding disorders before advising an invasive uterine surgical procedure for menorrhagia.
• The act does not apply to the public Hemophilia Treatment Program or other programs run by the Department of Rehabilitation Services, except for a specific prohibition related to insurer coverage in Section 4.
• Effective date: becomes law on the first day of the third month after passage and governor approval.

AI-generated summary using openai/gpt-5-nano on Feb 25, 2026. May contain errors — refer to the official bill text for accuracy.

Subjects

Health